Sivelestat for septic patients with acute respiratory distress syndrome: a systematic review and meta-analysis of a deadly duo

BackgroundAcute respiratory distress syndrome (ARDS) is one of the most common organ dysfunctions in sepsis. The potential benefits of sivelestat, a selective inhibitor of neutrophil elastase, for patients with septic ARDS remain unclear. The current systematic review and meta-analysis aimed to eval...

Full description

Bibliographic Details
Published in:	Frontiers in Medicine
Main Authors:	Wen-He Zheng, Yan-Ge Hu, Da-Xing Yu, Hui-Bin Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	sivelestat neutrophil elastase inhibitors acute respiratory distress syndrome mortality meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1679717/full

Similar Items

Effect of Neutrophil Elastase Inhibitor (Sivelestat Sodium) on Oxygenation in Patients with Sepsis-Induced Acute Respiratory Distress Syndrome
by: Wu T, et al.
Published: (2025-03-01)

Neutrophil elastase inhibitor (Sivelestat) in the treatment of acute respiratory distress syndrome induced by COVID-19: a multicenter retrospective cohort study
by: Yuting Li, et al.
Published: (2025-01-01)

The clinical effectiveness of sivelestat in treating sepsis patients with both acute respiratory distress syndrome and septic cardiomyopathy
by: Hui Lv, et al.
Published: (2024-06-01)

Effect of Sivelestat in the Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
by: Qiongli Ding, et al.
Published: (2023-06-01)

A neutrophil elastase inhibitor, sivelestat, attenuates sepsis-induced acute kidney injury by inhibiting oxidative stress
by: Wei Zhu, et al.
Published: (2024-04-01)

Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
by: Qiongli Ding, et al.
Published: (2022-08-01)

The In Vitro Inhibitory Effect of Sivelestat on Elastase Induced Collagen and Metallopeptidase Expression in Equine Endometrium
by: Ana Amaral, et al.
Published: (2020-05-01)

A comparative analysis of sivelestat sodium hydrate and ulinastatin combination therapy in the treatment of sepsis with acute respiratory distress syndrome
by: Jian Xu, et al.
Published: (2024-06-01)

Concomitant use of sivelestat sodium hydrate and antithrombotic drugs worsens the treatment outcome of patients with acute respiratory distress syndrome and suppression of fibrinolysis: a single-center, retrospective study
by: Takahiro Kato, et al.
Published: (2025-08-01)

Targeting neutrophil elastase is a promising direction for future cancer treatment
by: Wangqiang Jia, et al.
Published: (2024-05-01)

Efficacy Analysis and Prognostic Impact of Sivelestat Sodium in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
by: Xiao Che, et al.
Published: (2024-03-01)

Suppressive effects of the neutrophil elastase inhibitor sivelestat sodium hydrate on interleukin-1β production in lipopolysaccharide-stimulated porcine whole blood
by: Yasuyoshi Kurimoto, et al.
Published: (2020-02-01)

Neutrophil elastase: From mechanisms to therapeutic potential
by: Weilin Zeng, et al.
Published: (2023-04-01)

The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
by: Tuo Pan, et al.
Published: (2023-01-01)

Effect and safety of sivelestat on acute severe pancreatitis with systemic inflammatory response syndrome: a retrospective study
by: Jiafeng Xie, et al.
Published: (2025-01-01)

Corrigendum: The neutrophil elastase inhibitor, Sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
by: Tuo Pan, et al.
Published: (2023-03-01)

Sivelestat in Patients at a High Risk of Postoperative Acute Lung Injury After Scheduled Cardiac Surgery: A Prospective Cohort Study
by: Tang YX, et al.
Published: (2024-02-01)

DNase I and Sivelestat Ameliorate Experimental Hindlimb Ischemia-Reperfusion Injury by Eliminating Neutrophil Extracellular Traps
by: Wang CL, et al.
Published: (2023-02-01)

Sivelestat-Loaded Neutrophil-Membrane-Coated Antioxidative Nanoparticles for Targeted Endothelial Protection in Sepsis
by: Juexian Wei, et al.
Published: (2025-06-01)

Effect of sivelestat sodium on the incidence of ventilator-associated pneumonia in patients with sepsis and ARDS
by: Xingcheng Zhang, et al.
Published: (2025-08-01)

Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of ALI/ARDS patients with COVID-19
by: Ruiying Wang, et al.
Published: (2024-09-01)

Potential of Sivelestat for Pulmonary Arterial Hypertension Treatment: Network Pharmacology-Based Target Identification and Mechanistic Exploration
by: Deng X, et al.
Published: (2025-05-01)

Neutrophil elastase in bronchiectasis
by: Andrea Gramegna, et al.
Published: (2017-12-01)

Lung-homing nanoliposomes for early intervention in NETosis and inflammation during acute lung injury
by: Jungbum Kim, et al.
Published: (2025-02-01)

Research advances in NETs and acute respiratory distress syndrome
by: WANG Hang-hang, WANG Dao-xin
Published: (2021-07-01)

Acute respiratory distress syndrome in a patient with tuberculosis
by: Rabih Hallit, et al.
Published: (2020-09-01)

Efficacy of corticosteroids in patients with acute respiratory distress syndrome: a meta-analysis
by: Guowei Li, et al.
Published: (2024-12-01)

Lung ultrasound score and in-hospital mortality of adults with acute respiratory distress syndrome: a meta-analysis
by: Dandan Wang, et al.
Published: (2024-01-01)

Recruitment maneuvers in patients with acute respiratory distress syndrome: a systematic review and metanalysis
by: Alice Cardoso de Jesus, et al.
Published: (2024-12-01)

Prognostic value of time-varying dead space estimates in mechanically ventilated patients with acute respiratory distress syndrome
by: Lianlian Jiang, et al.
Published: (2024-04-01)

Sivelestat Sodium Alleviates Ischemia-Reperfusion-Induced Acute Kidney Injury via Suppressing TLR4/Myd88/NF-κB Signaling Pathway in Mice
by: Wang J, et al.
Published: (2024-10-01)

Ribociclib leverages phosphodiesterase 4 inhibition in the treatment of neutrophilic inflammation and acute respiratory distress syndrome
by: Po-Jen Chen, et al.
Published: (2024-08-01)

Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials
by: Xue-biao Wei, et al.
Published: (2020-01-01)

Bibliometric analysis of neutrophil elastase research in the post-COVID-19 era: trends, frontiers, differential mapping, and emerging trends
by: Siddig Ibrahim Abdelwahab, et al.
Published: (2025-03-01)

Prognostic value of neutrophils to lymphocytes and platelets ratio for 28-day mortality in patients with acute respiratory distress syndrome: a retrospective study
by: Shiyu Nie, et al.
Published: (2022-08-01)

Causes and characteristics of death in patients with acute hypoxemic respiratory failure and acute respiratory distress syndrome: a retrospective cohort study
by: Scott W. Ketcham, et al.
Published: (2020-07-01)

A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality
by: Philip van der Zee, et al.
Published: (2020-05-01)

Research on the process and molecular mechanism of inhibiting serous ovarian cancer by PRTN3 and its inhibitor Sivelestat
by: Changtao Zheng, et al.
Published: (2025-09-01)

Metabolic syndrome is associated with mortality in elderly patients with acute respiratory distress syndrome
by: Xiao Xu, et al.
Published: (2024-08-01)

Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup
by: Huikang Xu, et al.
Published: (2023-11-01)